🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "focused steps to tackle household expense pressures" in the upcoming Budget.

Speaking to media outlets, she emphasized that reducing price rises is a collective task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Possible Utility Bill Measures

Reports indicate the government could take action to lower energy bills, for instance by reducing the current 5% level of value-added tax applied on energy supplies.

An additional option is to lower some of the policy costs currently included in bills.

Budgetary Constraints and Analyst Expectations

The administration will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much space there is for such actions.

The expectation from most analysts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to fulfill her voluntary debt limits.

Earlier on Thursday, estimates indicated there was a £22bn shortfall for the chancellor to fill, which is at the more modest range of expectations.

"It is a shared job between the Bank of England and the administration to further reduce some of the causes of price increases," Reeves stated to reporters in Washington, at the conferences of the IMF and global financial institution.

Tax Commitments and International Issues

While much of the attention has been on likely tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing geopolitical and commercial concerns for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."

Global Economic Disputes

Addressing apprehensions about the UK's economic relations with the Asian nation she said: "The UK's security interests invariably are paramount."

Recent announcement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are crucial for high-technology manufacturing led US President the US President to threaten an additional 100% tariff on imports from China, raising the possibility of an full-scale trade war between the two global powers.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production power grab."

Inquired about considering the US offer to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese actions and called on the Chinese government "not to put up barriers and restrict access."

She said the decision was "bad for the international commerce and creates additional headwinds."

"I believe there are sectors where we should challenge Chinese policies, but there are also important opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to get that equilibrium appropriate."

The Treasury chief also affirmed she was collaborating with other major economies "on our own critical minerals plan, so that we are less reliant."

NHS Medicine Pricing and Funding

Reeves also recognized that the price the National Health Service spends on medicines could rise as a consequence of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

Some of the biggest global drug companies have said recently that they are either delaying or canceling operations in the UK, with several blaming the low prices they are getting.

Recently, the Science Minister said the price the NHS spends on drugs would must rise to stop companies and drug research funding departing from the UK.

The Chancellor informed the BBC: "We have seen because of the cost structure, that drug testing, innovative medicines have not been offered in the United Kingdom in the extent that they are in other continental states."

"We want to ensure that people getting treatment from the National Health Service are can access the top essential drugs in the globe. And so we are looking at all of that, and... looking to secure increased capital into the UK."